Amanote Research

Amanote Research

    RegisterSign In

Drug Company Payments to Doctors Still Hard to Access Despite Disclosure Laws

BMJ
doi 10.1136/bmj.39164.663044.db
Full Text
Open PDF
Abstract

Available in full text

Date

March 29, 2007

Authors
Fred Charatan
Publisher

BMJ


Related search

GPs Asked Not to Demand Payments From Drug Company Representatives

BMJ
2004English

Payments to Doctors and the Responsibilities of Ethics Committees

BMJ
1984English

Payments to Doctors and the Responsibilities of Ethics Committees

BMJ
1983English

The Prevalence of Patient Disclosure of HIV Infection to Doctors.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1995English

Disclosure of Social Responsibility, Profitability to Improve the Company Value

KnE Social Sciences
2019English

Correction: Milage Payments for Hospital Doctors

BMJ
1981English

Scottish Doctors Will Have to Register Financial Links to Drug Companies

BMJ
2004English

Doctors-Managers: Is Still Worthy?

Health Services Management Research
Health Policy
2017English

Australias Plan to Reduce Drug Spending Attacked by Doctors

BMJ
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy